1
|
David SRN, Mohammad MS, Chee LY, Rajabalaya R. Is Sunflower Cooking Oil Beneficial for Colorectal Cancer? In Vivo
Studies on Azoxymethane-induced Colon Cancer in Rats. CURRENT NUTRITION & FOOD SCIENCE 2022. [DOI: 10.2174/1573401317666211208144625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
The incorporation of oils in the diet may have promoting or inhibitory
effects on Colorectal Cancer (CRC). In this study, azoxymethane (AOM) was used to mimic CRC
in rats, and the effect of sunflower oil on cancer progression in the colon of the rats was tested.
Objective:
This study was conducted to investigate the effect of sunflower oil on preneoplastic
cancer properties of the colonic mucosal surface of tumors and the aberrant crypt foci (ACF).
Methods:
Six-week-old Sprague-Dawley male rats were randomized into 4 groups of 6 rats each,
namely naïve, positive control, negative control, and sunflower oil-fed. CRC was induced by AOM
by subcutaneous injection of 20 mg/kg. After CRC induction, the rats were given the respective
treatment of either basal diet (naïve group), 10 mg/kg indomethacin (positive control), 0.9 % saline
(negative control), or 7 % sunflower oil (experimental group) daily by oral gavage for 42 days.
Rats were sacrificed by cervical dislocation; colon samples were visually observed for any tumors
on the colonic mucosal surface and evaluated for ACF; histopathological examinations were also
performed.
Results:
The mean body weights of the rats were similar in all groups as per one-way ANOVA. A
total of 3 ACF were found in the negative group, while none were observed in other groups. The
crypts appeared regular with circular luminal openings and were closely packed together in the
naïve group. Crypts in the positive and treated group had a similar appearance to the naïve group.
Conclusion:
Sunflower oil inhibition of the preneoplastic cancer ACF properties were tested but
were found to be insignificant when administered during CRC treatment or management. However,
long-term experiments with a greater number of days will yield better development of tumor
and ACF development and will be useful in identifying the molecular mechanism.
Collapse
Affiliation(s)
- Sheba R. Nakka David
- PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link Gadong, Bandar Seri
Begawan-BE1410, Brunei Darussalam
| | - Miza Syazwina Mohammad
- PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link Gadong, Bandar Seri
Begawan-BE1410, Brunei Darussalam
| | - Lim Ya Chee
- PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link Gadong, Bandar Seri
Begawan-BE1410, Brunei Darussalam
| | - Rajan Rajabalaya
- PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link Gadong, Bandar Seri
Begawan-BE1410, Brunei Darussalam
| |
Collapse
|
2
|
Verma DK, Srivastav PP. Bioactive compounds of rice (Oryza sativa L.): Review on paradigm and its potential benefit in human health. Trends Food Sci Technol 2020. [DOI: 10.1016/j.tifs.2020.01.007] [Citation(s) in RCA: 54] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
3
|
Zarei I, Brown DG, Nealon NJ, Ryan EP. Rice Bran Metabolome Contains Amino Acids, Vitamins & Cofactors, and Phytochemicals with Medicinal and Nutritional Properties. RICE (NEW YORK, N.Y.) 2017; 10:24. [PMID: 28547736 PMCID: PMC5453916 DOI: 10.1186/s12284-017-0157-2] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Accepted: 04/21/2017] [Indexed: 05/06/2023]
Abstract
BACKGROUND Rice bran is a functional food that has shown protection against major chronic diseases (e.g. obesity, diabetes, cardiovascular disease and cancer) in animals and humans, and these health effects have been associated with the presence of bioactive phytochemicals. Food metabolomics uses multiple chromatography and mass spectrometry platforms to detect and identify a diverse range of small molecules with high sensitivity and precision, and has not been completed for rice bran. RESULTS This study utilized global, non-targeted metabolomics to identify small molecules in rice bran, and conducted a comprehensive search of peer-reviewed literature to determine bioactive compounds. Three U.S. rice varieties (Calrose, Dixiebelle, and Neptune), that have been used for human dietary intervention trials, were assessed herein for bioactive compounds that have disease control and prevention properties. The profiling of rice bran by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS) identified 453 distinct phytochemicals, 209 of which were classified as amino acids, cofactors & vitamins, and secondary metabolites, and were further assessed for bioactivity. A scientific literature search revealed 65 compounds with health properties, 16 of which had not been previously identified in rice bran. This suite of amino acids, cofactors & vitamins, and secondary metabolites comprised 46% of the identified rice bran metabolome, which substantially enhanced our knowledge of health-promoting rice bran compounds provided during dietary supplementation. CONCLUSION Rice bran metabolite profiling revealed a suite of biochemical molecules that can be further investigated and exploited for multiple nutritional therapies and medical food applications. These bioactive compounds may also be biomarkers of dietary rice bran intake. The medicinal compounds associated with rice bran can function as a network across metabolic pathways and this metabolite network may occur via additive and synergistic effects between compounds in the food matrix.
Collapse
Affiliation(s)
- Iman Zarei
- Department of Environmental & Radiological Health Sciences, College of Veterinary Medicine and Biological Sciences, Colorado State University, 1680 Campus Delivery, Fort Collins, CO 80523 USA
- Institute of Human Nutrition and Food, College of Human Ecology, University of the Philippines Los Baños, Los Baños, 4031 Laguna Philippines
| | - Dustin G. Brown
- Department of Environmental & Radiological Health Sciences, College of Veterinary Medicine and Biological Sciences, Colorado State University, 1680 Campus Delivery, Fort Collins, CO 80523 USA
| | - Nora Jean Nealon
- Department of Environmental & Radiological Health Sciences, College of Veterinary Medicine and Biological Sciences, Colorado State University, 1680 Campus Delivery, Fort Collins, CO 80523 USA
| | - Elizabeth P. Ryan
- Department of Environmental & Radiological Health Sciences, College of Veterinary Medicine and Biological Sciences, Colorado State University, 1680 Campus Delivery, Fort Collins, CO 80523 USA
| |
Collapse
|
4
|
Hypotheses on the Potential of Rice Bran Intake to Prevent Gastrointestinal Cancer through the Modulation of Oxidative Stress. Int J Mol Sci 2017; 18:ijms18071352. [PMID: 28672811 PMCID: PMC5535845 DOI: 10.3390/ijms18071352] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Revised: 06/14/2017] [Accepted: 06/20/2017] [Indexed: 12/15/2022] Open
Abstract
Previous studies have suggested the potential involvement of oxidative stress in gastrointestinal cancers. In light of this, research efforts have been focused on the potential of dietary antioxidant intake to prevent gastrointestinal cancer through the modulation of oxidative stress. Rice bran, a by-product of rice milling, has been shown to contain an abundance of phytochemicals, which are dietary antioxidants. To date, a number of studies have shown the antioxidative effect of rice bran intake, and some demonstrated that such an effect may contribute to gastrointestinal cancer prevention, largely through the antioxidative properties of rice bran phytochemicals. In addition, these phytochemicals were shown to provide protection against cancer through mechanisms linked to oxidative stress, including β-catenin-mediated cell proliferation and inflammation. The present article provides an overview of current evidence for the antioxidative properties of rice bran and its phytochemicals, and for the potential of such properties in cancer prevention through the oxidative-stress-linked mechanisms mentioned above. The article also highlights the need for an evaluation of the effectiveness of rice bran dietary interventions among cancer survivors in ameliorating oxidative stress and reducing the level of gastrointestinal cancer biomarkers, thereby establishing the potential of such interventions among these individuals in the prevention of cancer recurrence.
Collapse
|
5
|
Scientific Evidence of Rice By-Products for Cancer Prevention: Chemopreventive Properties of Waste Products from Rice Milling on Carcinogenesis In Vitro and In Vivo. BIOMED RESEARCH INTERNATIONAL 2017; 2017:9017902. [PMID: 28210630 PMCID: PMC5292171 DOI: 10.1155/2017/9017902] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Revised: 12/01/2016] [Accepted: 12/04/2016] [Indexed: 12/20/2022]
Abstract
Cancer is a significant global health concern affecting men and women worldwide. Although current chemopreventive drugs could inhibit the growth of cancer cells, they exert many adverse side effects. Dietary factor plays a crucial role in the management of cancers and has drawn the attention of researchers to be used as an option to combat this disease. Both in vitro and in vivo studies showed that rice and its by-products display encouraging results in the prevention of this disease. The mechanism of anticancer effect is suggested partly through potentiation of bioactive compounds like vitamin E, phytic acid, γ-aminobutyric acid (GABA), γ-oryzanol, and phenolics. Nevertheless, the bioactivity of rice and its by-products is still incompletely understood. In this review, we present the findings from a preclinical study both in in vitro and in animal experiments on the promising role of rice by-products with focus on cancer prevention.
Collapse
|
6
|
Ghoneum M, Agrawal S. Mgn-3/biobran enhances generation of cytotoxic CD8+ T cells via upregulation of dec-205 expression on dendritic cells. Int J Immunopathol Pharmacol 2015; 27:523-30. [PMID: 25572732 DOI: 10.1177/039463201402700408] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Arabinoxylan rice bran (MGN-3/Biobran) has been shown to be a potent biological response modifier (BRM) that activates different arms of the immune system, including dendritic cells (DCs), which prime CD4+ helper T-cell responses. The present study explores the ability of MGN-3-activated DCs to prime CD8+ T cells and examines the mechanisms underlying its effect. Human monocyte-derived DCs were treated with MGN-3 (20 and 40 μg/ml). Results indicate that treatment with MGN-3 caused DCs to prime higher granzyme B-expressing CD8+ T cells. Tumor lysate-pulsed MGN-3 DC also increased tumor cell killing compared to DC-stimulated CD8+ T cells. This was associated with: i) increased expression of DEC-205 in MGN-3-activated DCs in a dose-dependent manner; and ii) MGN-3 induced significant production of Type III interferon, IL29, but not Type I IFNs α and β. These results suggest that MGN-3 is a potent natural adjuvant that efficiently activates DCs and may therefore be useful for mounting an efficient immune response against infections and cancer.
Collapse
Affiliation(s)
- M Ghoneum
- Charles Drew University of Medicine and Science, Los Angeles, CA, U.S.A
| | - S Agrawal
- Division of Basic and Clinical Immunology, University of California, Irvine, CA, U.S.A
| |
Collapse
|
7
|
Forster GM, Raina K, Kumar A, Kumar S, Agarwal R, Chen MH, Bauer JE, McClung AM, Ryan EP. Rice varietal differences in bioactive bran components for inhibition of colorectal cancer cell growth. Food Chem 2013; 141:1545-52. [PMID: 23790950 DOI: 10.1016/j.foodchem.2013.04.020] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2012] [Revised: 03/08/2013] [Accepted: 04/08/2013] [Indexed: 11/25/2022]
Abstract
Rice bran chemical profiles differ across rice varieties and have not yet been analysed for differential chemopreventive bioactivity. A diverse panel of seven rice bran varieties was analysed for growth inhibition of human colorectal cancer (CRC) cells. Inhibition varied from 0% to 99%, depending on the variety of bran used. Across varieties, total lipid content ranged 5-16%, individual fatty acids had 1.4- to 1.9-fold differences, vitamin E isoforms (α-, γ-, δ-tocotrienols, and tocopherols) showed 1.3- to 15.2-fold differences, and differences in γ-oryzanol and total phenolics ranged between 100-275ng/mg and 57-146ngGAE/mg, respectively. Spearman correlation analysis was used to identify bioactive compounds implicated in CRC cell growth inhibitory activity. Total phenolics and γ-tocotrienol were positively correlated with reduced CRC cell growth (p<0.05). Stoichiometric variation in rice bran components and differential effects on CRC viability merit further evaluation elucidate their role in dietary CRC chemoprevention.
Collapse
Affiliation(s)
- Genevieve M Forster
- Department of Environmental and Radiological Health Sciences, Colorado State University, 1681 Campus Delivery Fort Collins, CO 80523, United States
| | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Henderson AJ, Ollila CA, Kumar A, Borresen EC, Raina K, Agarwal R, Ryan EP. Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr 2012; 3:643-53. [PMID: 22983843 PMCID: PMC3648746 DOI: 10.3945/an.112.002303] [Citation(s) in RCA: 120] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Emerging evidence suggests that dietary rice bran may exert beneficial effects against several types of cancer, such as breast, lung, liver, and colorectal cancer. The chemopreventive potential has been related to the bioactive phytochemicals present in the bran portion of the rice such as ferulic acid, tricin, β-sitosterol, γ-oryzanol, tocotrienols/tocopherols, and phytic acid. Studies have shown that the anticancer effects of the rice bran-derived bioactive components are mediated through their ability to induce apoptosis, inhibit cell proliferation, and alter cell cycle progression in malignant cells. Rice bran bioactive components protect against tissue damage through the scavenging of free radicals and the blocking of chronic inflammatory responses. Rice bran phytochemicals have also been shown to activate anticancer immune responses as well as affecting the colonic tumor microenvironment in favor of enhanced colorectal cancer chemoprevention. This is accomplished through the modulation of gut microflora communities and the regulation of carcinogen-metabolizing enzymes. In addition, the low cost of rice production and the accessibility of rice bran make it an appealing candidate for global dietary chemoprevention. Therefore, the establishment of dietary rice bran as a practical food-derived chemopreventive agent has the potential to have a significant impact on cancer prevention for the global population.
Collapse
Affiliation(s)
- Angela J. Henderson
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO
| | - Cadie A. Ollila
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO
| | - Ajay Kumar
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO
| | - Erica C. Borresen
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO
| | - Komal Raina
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anshutz Medical Campus, Aurora, CO; and
| | - Rajesh Agarwal
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anshutz Medical Campus, Aurora, CO; and,University of Colorado Cancer Center, University of Colorado, Aurora, CO
| | - Elizabeth P. Ryan
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO,University of Colorado Cancer Center, University of Colorado, Aurora, CO,To whom correspondence should be addressed. E-mail:
| |
Collapse
|